Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7494
Revised: September 10, 2013
Accepted: September 16, 2013
Published online: November 21, 2013
Processing time: 132 Days and 10.8 Hours
Core tip: High-intensity focused ultrasound (HIFU) is a non-invasive modality used to destroy tissue. It has been used to treat unresectable advanced stages of hepatocellular carcinoma (HCC) and liver metastases. In some HCC cases, liver transplantation has become one of the best treatments because it removes the tumour and the underlying liver disease such as cirrhosis. The so-called “bridging therapy” has the aim of controlling disease burden for patients who are on the organ transplant waiting list. Here, we discuss various treatment options including transarterial chemoembolisation and radiofrequency ablation, and we examine the utility of HIFU as a safe and effective method of bridging therapy that can reduce the dropout rate of patients who are on the liver transplant waiting list.